MY117328A - Production process for intravenous immune serum globulin and resultant product. - Google Patents

Production process for intravenous immune serum globulin and resultant product.

Info

Publication number
MY117328A
MY117328A MYPI98005848A MYPI9805848A MY117328A MY 117328 A MY117328 A MY 117328A MY PI98005848 A MYPI98005848 A MY PI98005848A MY PI9805848 A MYPI9805848 A MY PI9805848A MY 117328 A MY117328 A MY 117328A
Authority
MY
Malaysia
Prior art keywords
production process
resultant product
immune serum
intravenous immune
serum globulin
Prior art date
Application number
MYPI98005848A
Other languages
English (en)
Inventor
Raja R Mamida
Bagdasarian Andranik
Canaveral Gorgonio
Kazuo Takechi
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of MY117328A publication Critical patent/MY117328A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI98005848A 1997-12-24 1998-12-23 Production process for intravenous immune serum globulin and resultant product. MY117328A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99795297A 1997-12-24 1997-12-24

Publications (1)

Publication Number Publication Date
MY117328A true MY117328A (en) 2004-06-30

Family

ID=25544595

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98005848A MY117328A (en) 1997-12-24 1998-12-23 Production process for intravenous immune serum globulin and resultant product.

Country Status (15)

Country Link
EP (1) EP0971727A4 (ru)
JP (1) JP2001514672A (ru)
KR (1) KR20000075562A (ru)
CN (1) CN1214042C (ru)
AR (1) AR018260A1 (ru)
AU (1) AU747893B2 (ru)
BR (1) BR9807598A (ru)
CA (1) CA2281938A1 (ru)
CO (1) CO4970799A1 (ru)
IL (1) IL131471A0 (ru)
MY (1) MY117328A (ru)
RU (1) RU2198668C2 (ru)
TW (1) TW546144B (ru)
UA (1) UA64742C2 (ru)
WO (1) WO1999033484A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4685238B2 (ja) * 1998-06-09 2011-05-18 ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
JP2003501480A (ja) * 1999-06-15 2003-01-14 アルファ・セラピューティック・コーポレーション 静注用免疫グロブリンの製造方法および製剤
WO2002026258A2 (en) * 2000-09-28 2002-04-04 Research Corporation Technologies, Inc. Treatment of immune-mediated diseases by oral administration of plasma fractions
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
US6893639B2 (en) 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
CN100522989C (zh) 2002-09-11 2009-08-05 中外制药株式会社 纯化蛋白质的方法
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
KR100791502B1 (ko) * 2006-09-29 2008-01-03 한스바이오메드 주식회사 바이러스 불활화된 무세포 인체 이식재 생산방법
CA2742817A1 (en) * 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
CA2941230C (en) 2014-03-11 2020-08-25 Green Cross Holdings Corporation Method for purifying immunoglobulin
CN107880116B (zh) * 2016-09-30 2023-02-03 盖立复集团公司 用于制备免疫球蛋白的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
JP2965069B2 (ja) * 1989-01-13 1999-10-18 吉富製薬株式会社 蛋白質含有組成物の製造方法
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
DE69027187T2 (de) * 1989-06-15 1996-10-31 Rorer Int Overseas Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
DE4431833C1 (de) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines AHF-Konzentrates
JP4003235B2 (ja) * 1994-09-30 2007-11-07 三菱ウェルファーマ株式会社 静注用免疫グロブリン製剤の製造方法

Also Published As

Publication number Publication date
JP2001514672A (ja) 2001-09-11
CN1252729A (zh) 2000-05-10
IL131471A0 (en) 2001-01-28
AU747893B2 (en) 2002-05-30
KR20000075562A (ko) 2000-12-15
BR9807598A (pt) 2000-02-22
EP0971727A1 (en) 2000-01-19
CA2281938A1 (en) 1999-07-08
WO1999033484A1 (en) 1999-07-08
UA64742C2 (ru) 2004-03-15
EP0971727A4 (en) 2005-01-19
AU1703899A (en) 1999-07-19
CN1214042C (zh) 2005-08-10
TW546144B (en) 2003-08-11
RU2198668C2 (ru) 2003-02-20
AR018260A1 (es) 2001-11-14
CO4970799A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
MY117328A (en) Production process for intravenous immune serum globulin and resultant product.
GR3034177T3 (en) Immunoglobulin g concentrate for therapeutical use and method for producing same
EP0128522A3 (en) High titer cytomegalovirus immune serum globulin and method of making same
FR2651437B1 (ru)
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
PL299346A1 (en) Method of theating articles of food and theirt byproducts, articles of food and their byproducts obtained thereby and use of adsorptive resins for treating articles of food and their byproducts
GB1488774A (en) Hepatitis b antigen and method of producing it
AU2253392A (en) Therapeutic fragments of von willebrand factor
BR0010815A (pt) Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa
ES8705230A1 (es) Procedimiento para preparar gamma-globulinas administrables por via intravenosa
ZA971998B (en) Purification method.
SG86990A1 (en) Process for the quantitative purification of glycolipids
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
BR0011648A (pt) Método de fabricação de imunoglobulina intravenosa e produto resultante
FI893389A (fi) Foerfarande foer framstaellning av fosfater genom smaeltning.
AU1516988A (en) Method of preparing highly purified alpha-1-proteinase inhibitor
AU4811290A (en) A pure factor i protein and a process for producing said protein
PT79232A (en) Process for producing immune interferon and of pharmaceutical compositions containing the same
FI951836A0 (fi) Menetelmä reaktiotuotteiden valmistamiseksi polydiorganosiloksaaneista
DE3467973D1 (en) Process for the stabilization of hematin